These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11678523)

  • 1. Captopril-induced jaundice: report of 2 cases and a review of 13 additional reports in the literature.
    Schattner A; Kozak N; Friedman J
    Am J Med Sci; 2001 Oct; 322(4):236-40. PubMed ID: 11678523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Captopril-associated "pseudocholangitis'. A case report and review of the literature.
    Nissan A; Spira RM; Seror D; Ackerman Z
    Arch Surg; 1996 Jun; 131(6):670-1. PubMed ID: 8645078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Captopril-associated cholestasis complicating the management of pancreatic cancer.
    Kocab MA; Coppola D; Hiotis S; Karl RC; Barthel JS
    Surg Endosc; 2000 Jul; 14(7):681. PubMed ID: 11265073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Captopril-associated cholestatic jaundice.
    Rahmat J; Gelfand RL; Gelfand MC; Winchester JF; Schreiner GE; Zimmerman HJ
    Ann Intern Med; 1985 Jan; 102(1):56-8. PubMed ID: 3881069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ramipril-associated hepatotoxicity.
    Yeung E; Wong FS; Wanless IR; Shiota K; Guindi M; Joshi S; Gardiner G
    Arch Pathol Lab Med; 2003 Nov; 127(11):1493-7. PubMed ID: 14567716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Captopril-induced cholestatic jaundice.
    Hagley MT
    South Med J; 1991 Jan; 84(1):100. PubMed ID: 1986415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of fosinopril-induced severe cholestatic jaundice with plasma exchange.
    Chou JW; Yu CJ; Chuang PH; Lai HC; Hsu CH; Cheng KS; Peng CY; Chiang IP
    Ann Pharmacother; 2008 Dec; 42(12):1887-92. PubMed ID: 19017832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fosinopril-induced prolonged cholestatic jaundice and pruritus: first case report.
    Nunes AC; Amaro P; Maç as F; Cipriano A; Martins I; Rosa A; Pimenta I; Donato A; Freitas D
    Eur J Gastroenterol Hepatol; 2001 Mar; 13(3):279-82. PubMed ID: 11293449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cholestatic hepatitis caused by captopril].
    Pérez Roldán F; González Carro PS; Legaz Huidobro ML; Saez Bravo JM; Ruiz Carrillo F
    Rev Esp Enferm Dig; 1998 May; 90(5):378-9. PubMed ID: 9656763
    [No Abstract]   [Full Text] [Related]  

  • 10. Cholestatic jaundice associated with captopril therapy.
    Crantock L; Prentice R; Powell L
    J Gastroenterol Hepatol; 1991; 6(5):528-30. PubMed ID: 1932674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatotoxicity associated with angiotensin-converting enzyme inhibitors.
    Hagley MT; Hulisz DT; Burns CM
    Ann Pharmacother; 1993 Feb; 27(2):228-31. PubMed ID: 8292107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Captopril-induced liver dysfunction.
    Tabibian N; Alpert L; Alpert E
    South Med J; 1987 Sep; 80(9):1173-5. PubMed ID: 3306948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cholestatic jaundice induced by captopril].
    de Vega T; Rúa-Figueroa I; Soto J; Sacristán JA
    Med Clin (Barc); 1992 Apr; 98(13):518. PubMed ID: 1583956
    [No Abstract]   [Full Text] [Related]  

  • 14. [Progressive icterus in a 56 years old man].
    Fernández Alons E; San Román Montero JM; Cabello Clotet N; Gargantilla Madera P; Garzarán A; Vergas García J; Pardo Redondo A
    An Med Interna; 2002 Jul; 19(7):380-1. PubMed ID: 12224153
    [No Abstract]   [Full Text] [Related]  

  • 15. Ramipril-induced liver injury: case report and review of the literature.
    Douros A; Kauffmann W; Bronder E; Klimpel A; Garbe E; Kreutz R
    Am J Hypertens; 2013 Sep; 26(9):1070-5. PubMed ID: 23747952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Angioedema of the tongue and oropharynx after treatment with sublingual captopril].
    Arzi H; Ben-Dror G; Mijiritzky Y
    Harefuah; 2002 Oct; 141(10):869-70, 931. PubMed ID: 12420588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.
    Pfeffer MA; McMurray JJ; Velazquez EJ; Rouleau JL; Køber L; Maggioni AP; Solomon SD; Swedberg K; Van de Werf F; White H; Leimberger JD; Henis M; Edwards S; Zelenkofske S; Sellers MA; Califf RM;
    N Engl J Med; 2003 Nov; 349(20):1893-906. PubMed ID: 14610160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suspected cross-reactivity of enalapril- and captopril-induced hepatotoxicity.
    Hagley MT; Benak RL; Hulisz DT
    Ann Pharmacother; 1992 Jun; 26(6):780-1. PubMed ID: 1611160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Captopril-induced cholestatic jaundice.
    Parker WA
    Drug Intell Clin Pharm; 1984 Mar; 18(3):234-5. PubMed ID: 6365496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.